美股異動|特斯拉盤前升超1% Model 3全球銷量達300萬輛 本週將發財報
上週五(18日)收升3.21%的特斯拉(TSLA.US)今日美股盤前續升1.42%,報334.34美元。消息面上,特斯拉Model 3全球銷量達300萬輛,連續7年蟬聯全球純電轎車銷冠。此外,馬斯克就Robotaxi表示,隨着我們將奧斯汀Robotaxi的升級整合到一般的生產版本中,特斯拉汽車的自動駕駛能力將有一個階級式的躍升。我們需要驗證在奧斯汀Robotaxi的優化不會導致其他方面的退化。在歐洲等地區,正在等待監管部門的批准,有望很快獲批。另外據悉,特斯拉將於美東時間7月23日盤後發佈財報。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.